Bolthouse Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$442K Hold
481
0.4% 48
2025
Q4
$517K Hold
481
0.46% 43
2025
Q3
$367K Hold
481
0.33% 53
2025
Q2
$375K Sell
481
-219
-31% -$170K 0.37% 54
2025
Q1
$578K Hold
700
0.6% 36
2024
Q4
$540K Buy
+700
New +$580K 0.5% 42

Other funds holding LLY

Bolthouse Investments's LLY Position: Q1 2026 in Review

Bolthouse Investments held its Eli Lilly (LLY) position steady in Q1 2026 at 481 shares worth $442K. The position accounts for 0.4% of the portfolio, ranked #48.

Bolthouse Investments first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $578K in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bolthouse Investments held 481 shares of Eli Lilly worth $442K as of Q1 2026.
  • Bolthouse Investments left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.4% of Bolthouse Investments's portfolio in Q1 2026, its #48 holding.
  • Bolthouse Investments first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Bolthouse Investments's Eli Lilly position peaked at $578K in Q1 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bolthouse Investments's 13F filing for Q1 2026, filed 28 Apr 2026.